About LatchBio
LatchBio is a Healthcare company based in San Francisco (United States) founded in 2021 by Alfredo Andere, Kyle Giffin, and Kenny Workman. A data platform for biology and biopharma RD is provided by LatchBio. It operates on a SaaS (Software-as-a-Service) and Pay-per-Use / Usage-Based model. LatchBio has raised $38 million across 3 funding rounds from investors including Coatue, Lux Capital and Hummingbird Ventures. Its chief executive, as recorded, is Alfredo Andere. Its website latch.bio draws about 23 thousand monthly visits. LatchBio offers products and services including LatchBio Platform, Analysis Packages, and Gene Editing Toolkit. Its focus areas include Technology, Biotechnology and Bioinformatics. Its competitors include Helix, Benchling and BioAge Labs; 3 of its 3 listed competitors have raised funding.
Company details
A modular and programmable data infrastructure is offered by LatchBio to accelerate biopharma RD. Solutions for solution providers and RD teams are developed, focusing on white-labeled analysis portals and unified workflows. Sectors such as drug discovery and bioinformatics are targeted, with tools for gene editing, RNA-Seq, and spatial transcriptomics being provided. Collaboration and reproducibility in biological data processing are enhanced through scalable cloud resources and customizable pipelines.
- Total Equity Funding$38M (USD)
in 3 rounds
- Latest Funding Round$28M (USD), Series A
Jun 2022
- InvestorsCoatue
& 7 more
Products & Services of LatchBio
LatchBio offers a comprehensive portfolio of products and services, including LatchBio Platform, Analysis Packages, and Gene Editing Toolkit.
A platform for accelerating biopharma R&D processes.
Customizable analysis portals for assay data processing.
Tools for CRISPR and gene editing analysis.
Funding Insights of LatchBio
LatchBio has successfully raised a total of $38M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $28 million completed in June 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $38M
- Total Rounds 3
- Last Round Series A — $28M
- First Round $5M
(Oct 2021)
- Investors Count 8
All 3 funding rounds of LatchBio with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2022 | $28M | Series A | – | Coatue, Lux Capital | |
| Oct 2021 | $5M | Seed | – | – | |
| Oct 2021 | $5M | Seed | – | Lux Capital |
8 investors in total: 7 institutional and 1 angel.
Investors in LatchBio
LatchBio has secured backing from 8 investors, including venture fund and angel investors. Prominent investors backing the company include Coatue, Lux Capital and Hummingbird Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Provider of an investment platform for various stages | coatue.com | New York, United States | ||
Seed and early-stage technology companies are funded by Lux Capital. | luxcapital.com | Menlo Park, United States | ||
Investments in early-stage startups are focused on by Hummingbird Ventures. | hummingbird.vc | London, United Kingdom | ||
A venture firm based in San Francisco and New York, investments are made in technology companies. | caffeinatedcapital.com | San Francisco, United States | ||
Venture capital firm focused on multiple sectors | fiftyyears.com | San Francisco, United States | ||
Multiple-stage venture capital investments are managed by Haystack. | haystack.vc | Menlo Park, United States | ||
Investment and transformation services for entrepreneurs in technology and finance sectors. | generalcatalyst.com | |||
AN Alec Nielsen | Angel investor and entrepreneur, co-founder of JetSetGo, focused on aviation and tech. | unknown_74b3f44a366748e58 |
Investor details for LatchBio
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of LatchBio
16 people are tracked at LatchBio (5 in leadership, 7 in board & advisors, 4 in team).
| Name | Role | Group |
|---|---|---|
Alfredo Andere | Co-Founder & CEO | Leadership |
Kyle Giffin | Co-Founder & COO | Leadership |
Kenny Workman | Co-Founder & CTO | Leadership |
Jordan Ramsay | Chief of Staff | Leadership |
Danny Levy | Head of Talent Acquisition | Leadership |
George Church | Advisor | Board & advisors |
Jeff Dean | Advisor | Board & advisors |
Laura Deming | Advisor | Board & advisors |
Hemant Taneja | Advisor | Board & advisors |
Brian Naughton | Advisor | Board & advisors |
Alec Nielsen | Advisor | Board & advisors |
Brandon White | Advisor | Board & advisors |
Ayush Kamat | Engineer | Team |
Aidan Abdulali | Founding Engineer | Team |
Hannah Le | Product Manager | Team |
Nathan Manske | Founding Designer | Team |
Complete people profiles for LatchBio
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of LatchBio
3 dated milestones of LatchBio across 1 years, from founding to its latest funding, stage changes and deals.
- Founded LatchBio is founded.
- Funding First funding round of $5.0M.
- Funding Latest funding round, Series A, of $28.0M.
Competitors of LatchBio
LatchBio has 3 listed competitors in our database, 3 of them funded. They include Helix, Benchling and BioAge Labs.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| helix.com | 2015 | San Francisco, United States | $435M | Genomic database for clinical research is provided. | ||
| benchling.com | 2012 | San Francisco, United States | $411.9M | 640 | Cloud-based bioinformatics platform is offered for biotech research. | |
| bioagelabs.com | 2015 | Vallejo, United States | $293.9M | 43 | Bioinformatics platform is provided for biomarkers and drug discovery. |
Detailed competitors of LatchBio
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of LatchBio
The website of LatchBio (latch.bio) receives about 23K visits a month.
- Monthly visits23K
▲ 26.9% vs previous month
Websites whose visitors overlap most with LatchBio. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
oligotherapeutics.org | oligotherapeutics.org | 100% | #2,047,167 | – | |
nf-co.re | nf-co.re | 80% | #301,377 | – | |
| navagis.com | 30% | 2.4K | #7,816,324 | View details | |
enclosures-dls.com | enclosures-dls.com | 29% | #13,734,327 | – | |
voxturrlabs.com | voxturrlabs.com | 29% | #4,874,768 | – | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 18 similar websites and full traffic analytics for LatchBio
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 18 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as LatchBio (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Latchbio
Complete news archive for LatchBio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about LatchBio
LatchBio was founded in 2021.
LatchBio is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Alfredo Andere is the CEO of LatchBio, as recorded in our data. They have also founded this company.
LatchBio is a funded company, having raised a total of $38M across 3 funding rounds to date. The company's 1st funding round was a Seed of $5M, raised on Oct 2021.
A modular and programmable data infrastructure is offered by LatchBio to accelerate biopharma RD. Solutions for solution providers and RD teams are developed, focusing on white-labeled analysis portals and unified workflows. Sectors such as drug discovery and bioinformatics are targeted, with tools for gene editing, RNA-Seq, and spatial transcriptomics being provided. Collaboration and reproducibility in biological data processing are enhanced through scalable cloud resources and customizable pipelines.
LatchBio's top competitors include Helix, Benchling and BioAge Labs.
LatchBio offers LatchBio Platform, Analysis Packages, and Gene Editing Toolkit.
LatchBio has 8 investors. Key investors include Coatue, Lux Capital, Hummingbird Ventures, Caffeinated Capital, and Fifty Years.